[HTML][HTML] Performance evaluation of the Roche Elecsys anti-SARS-CoV-2 S immunoassay
E Riester, P Findeisen, JK Hegel, M Kabesch… - Journal of virological …, 2021 - Elsevier
The Elecsys® Anti-SARS-CoV-2 S immunoassay (Roche Diagnostics International Ltd,
Rotkreuz, Switzerland) has been developed for the detection of antibodies to the severe acute …
Rotkreuz, Switzerland) has been developed for the detection of antibodies to the severe acute …
[HTML][HTML] Outcome prediction by serum calprotectin in patients with COVID-19 in the emergency department
…, J Ulke, N Galtung, A Havelka, JK Hegel… - The Journal of …, 2021 - ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19), caused by the SARS-CoV-2 virus, becomes
clinically manifest in a broad range from mild symptoms to life-threatening multi-organ failure (…
clinically manifest in a broad range from mild symptoms to life-threatening multi-organ failure (…
CTLA‐4 (CD 152) enhances the T c17 differentiation program
J Pick, A Arra, H Lingel, JK Hegel… - European journal of …, 2014 - Wiley Online Library
Although CD 8 + T cells that produce IL ‐17 ( T c17 cells) have been linked to host defense,
T c17 cells show reduced cytotoxic activity, which is the characteristic function of CD 8 + T …
T c17 cells show reduced cytotoxic activity, which is the characteristic function of CD 8 + T …
Performance evaluation of the Elecsys PIVKA‐II and Elecsys AFP assays for hepatocellular carcinoma diagnosis
…, M Kudo, J Trojan, A Eiblmaier, HG Klein, JK Hegel… - JGH …, 2022 - Wiley Online Library
Background and Aims Prothrombin induced by vitamin K absence‐II (PIVKA‐II) is a serum
biomarker linked to hepatocellular carcinoma (HCC), showing superiority to alpha‐fetoprotein …
biomarker linked to hepatocellular carcinoma (HCC), showing superiority to alpha‐fetoprotein …
[HTML][HTML] Multicentre performance evaluation of the Elecsys Anti-SARS-CoV-2 immunoassay as an aid in determining previous exposure to SARS-CoV-2
…, C Tinguely, P Findeisen, JK Hegel… - Infectious Diseases and …, 2021 - Springer
Introduction We performed a multicentre evaluation of the Elecsys ® Anti-SARS-CoV-2
immunoassay (Roche Diagnostics), an assay utilising a recombinant protein representing the …
immunoassay (Roche Diagnostics), an assay utilising a recombinant protein representing the …
[HTML][HTML] Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies
…, M Kudo, A Eiblmaier, HG Klein, JK Hegel… - Hepatology …, 2023 - journals.lww.com
Background: Alpha-fetoprotein (AFP) and des-gamma carboxyprothrombin (DCP), also known
as protein induced by vitamin K absence-II (PIVKA-II [DCP]) are biomarkers for HCC with …
as protein induced by vitamin K absence-II (PIVKA-II [DCP]) are biomarkers for HCC with …
[HTML][HTML] An isotope dilution-liquid chromatography-tandem mass spectrometry (ID-LC-MS/MS)-based candidate reference measurement procedure (RMP) for the …
…, JK Hegel, C Geletneky, J Taibon - Clinical Chemistry and …, 2023 - degruyter.com
… Lena Ruhe, Anett Engel, and Johannes Kolja Hegel are all employees of Labor Berlin –
Charité Vivantes Services GmbH, Berlin, Germany. Annika I. Ostermann and Tamara …
Charité Vivantes Services GmbH, Berlin, Germany. Annika I. Ostermann and Tamara …
[PDF][PDF] A comparative analysis of Elecsys GALAD and Elecsys GAAD score to detect early-stage hepatocellular carcinoma in an international cohort
…, K Malinowsky, P Findeisen, HG Klein, JK Hegel… - J Hepatol, 2022 - labor-limbach.de
Introduction Page 1 A comparative analysis of Elecsys GALAD and Elecsys GAAD score to
detect early-stage hepatocellular carcinoma in an international cohort Henry Lik-Yuen Chan,1 …
detect early-stage hepatocellular carcinoma in an international cohort Henry Lik-Yuen Chan,1 …
[PDF][PDF] Development, clinical validation and implementation of a novel algorithmic score (GAAD) for the detection of early-stage hepatocellular carcinoma
…, A Eiblmaier, HG Klein, JK Hegel… - Journal of …, 2023 - postersessiononline.eu
• Early-stage hepatocellular carcinoma (HCC) is often asymptomatic, with symptoms appearing
during the advanced stages of disease where prognosis is poor due to limited treatment …
during the advanced stages of disease where prognosis is poor due to limited treatment …
CTLA‐4 (CD152) controls homeostasis and suppressive capacity of regulatory T cells in mice
P Kolar, K Knieke, JKE Hegel, D Quandt… - Arthritis & …, 2009 - Wiley Online Library
Objective CD4+CD25+ regulatory T cells (known as Treg cells) suppress unwanted and
autoreactive T cell responses. Treg cells express the costimulatory molecule CTLA‐4 …
autoreactive T cell responses. Treg cells express the costimulatory molecule CTLA‐4 …
